Human chorionic gonadotropin as a biological marker in breast carcinoma

R. Gucalp, D. Firat

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Serum HCG levels were determined in benign and malignant breast tumor patients. Serum HCG levels were elevated in 1/18 (5.6%) benign, 8/27 (29.6%) localised and 15/41 (36.6%) metastatic breast carcinoma cases. The incidence of HCG elevation increased with multiple sites of involvement. The incidence of HCG elevation was similar for different organ sites of involvement. In view of these observations, the serum HCG levels may be of value in the differentiation of benign and malignant breast tumors, but have no value in the staging of breast carcinomas.

Original languageEnglish (US)
Pages (from-to)23-30
Number of pages8
JournalKanser
Volume10
Issue number1
StatePublished - Jan 1 1980
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Human chorionic gonadotropin as a biological marker in breast carcinoma'. Together they form a unique fingerprint.

  • Cite this